Global Lead, Attack Surface Management
Danaher
Global Lead, Attack Surface Management
Danaher
Makes tools for drug research and medical testing
Bring more to life.
At Danaher, our work saves lives. And each of us plays a part. Fueled by our culture of continuous improvement, we turn ideas into impact – innovating at the speed of life.
Our 60,000+ associates work across the globe at more than 15 unique businesses within life sciences, diagnostics, and biotechnology.
Are you ready to accelerate your potential and make a real difference? At Danaher, you can build an incredible career at a leading science and technology company, where we’re committed to hiring and developing from within. You’ll thrive in a culture of belonging where you and your unique viewpoint matter.
Learn about the Danaher Business System which makes everything possible.
At Danaher, the Global Lead, Attack Surface Management owns the ASM/EASM/CAASM capability — discovery, attribution, asset ownership, risk prioritization, and cross-functional remediation across internet-facing, internal, cloud, SaaS, subsidiary, and third-party surfaces. Enterprise strategy is set by leadership; the Global Lead shapes and refines the ASM strategy, then owns operationalizing it as part of CTEM. The Global Lead works independently and drives remediation across teams that each own their own assets.
This position reports to the Senior Manager, Exposure Management (CTEM) and is part of the Danaher Information Security (DIS) located in Poland (Remote).
This is a Danaher Corporate role, hosted by our Cytiva operating company in Kraków.
In this role, you will have the opportunity to:
The essential requirements of the job include:
It would be a plus if you also possess previous experience in:
#LI-KK1
Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.
For more information, visit www.danaher.com.
Danaher makes instruments, tests and laboratory supplies for drug developers, researchers and clinicians, spanning the path from biological research to clinical patient diagnosis. Its businesses include Cytiva for drug manufacturing, SCIEX for chemical analysis and Beckman Coulter for laboratory testing, linking specialized tools across healthcare workflows. Customers use its equipment to study cells, produce biological medicines and analyze patient samples; the group earns money by selling instruments, reagents, software and support services through its operating companies. Danaher was established in 1984 and is headquartered in Washington, DC.
Explore more opportunities at Danaher